Novo Nordisk
Institution · Empresa
1 recent article · 3 articles in the archive
Events in the news
Wegovy llegará a Chile en el primer semestre para el tratamiento de la obesidad
Los efectos sobre la obesidad y salud cardiovascular de Wegovy, la inyecciónSources and dates of the event
About this event
- Date of event
- June 16, 2026
- Publication date
- June 16, 2026
- Available confidence
- 90%
- Proximity
- Information not available
Sources
Normalized entities
Information not available
What changed
Information not available
Correction
Information not available
Score components
Information not available
Novo Nordisk lanzó oficialmente Wegovy en Chile para tratar la obesidad.
Laboratorio que creó el Ozempic lanza en Chile nuevo medicamento para laSources and dates of the event
About this event
- Date of event
- June 15, 2026
- Publication date
- June 15, 2026
- Available confidence
- 100%
- Proximity
- Information not available
Sources
- Laboratorio que creó el Ozempic lanza en Chile nuevo medicamento para laIn Spanish · Artículo vinculado
Normalized entities
Information not available
What changed
Information not available
Correction
Information not available
Score components
Information not available
Novo Nordisk sube 8% en bolsa por éxito de Wegovy en trimestre 2026-Q1
Novo Nordisk se dispara en bolsa tras elevar su proyección de ganancias porSources and dates of the event
About this event
- Date of event
- May 6, 2026
- Publication date
- May 6, 2026
- Available confidence
- 90%
- Proximity
- Information not available
Sources
Normalized entities
Information not available
What changed
Information not available
Correction
Information not available
Score components
Information not available
India comercializa genéricos de semaglutida tras expiración de patente Novo Nordisk
Ozempic genérico: India ya vende versión más económica y Chile alista "Selfix"Sources and dates of the event
About this event
- Date of event
- March 22, 2026
- Publication date
- March 23, 2026
- Available confidence
- 92%
- Proximity
- Information not available
Sources
Normalized entities
Information not available
What changed
Information not available
Correction
Information not available
Score components
Information not available
FDA aprueba Wegovy para pérdida de peso en Estados Unidos
La batalla por la supremacía en la pérdida de peso se traslada de lasSources and dates of the event
About this event
- Date of event
- December 31, 2025
- Publication date
- March 16, 2026
- Available confidence
- 90%
- Proximity
- Information not available
Sources
- La batalla por la supremacía en la pérdida de peso se traslada de lasIn Spanish · Artículo vinculado
Normalized entities
Information not available
What changed
Information not available
Correction
Information not available
Score components
Information not available
Dos estudios científicos demostraron beneficios de Wegovy para la obesidad y salud cardiovascular
Los efectos sobre la obesidad y salud cardiovascular de Wegovy, la inyecciónSources and dates of the event
About this event
- Date of event
- Information not available
- Publication date
- June 16, 2026
- Available confidence
- 90%
- Proximity
- Information not available
Sources
Normalized entities
Information not available
What changed
Information not available
Correction
Information not available
Score components
Information not available
Wegovy (semaglutida alta dosis) llegará a Chile en 2026
Confirman la fecha de llegada de Wegovy a Chile: el tratamiento más fuerte queSources and dates of the event
About this event
- Date of event
- Information not available
- Publication date
- April 24, 2026
- Available confidence
- 80%
- Proximity
- Information not available
Sources
Normalized entities
Information not available
What changed
Information not available
Correction
Information not available
Score components
Information not available
Latest stories
- Public Health Institute approves Picmagluti, Chile's first generic semaglutide
Farmacéutica danesa que desarrolló Ozempic y comercializa semaglutida en Chile.
Mentioned